Precipio, Inc. (PRPO) Reaches $0.70 52 Week Low; TECHNIP ADS (TKPPY) Had 3 Analysts Last Week

February 24, 2018 - By Peter Erickson

Among 7 analysts covering Technip (OTCMKTS:TKPPY), 3 have Buy rating, 2 Sell and 2 Hold. Therefore 43% are positive. Technip had 7 analyst reports since July 22, 2015 according to SRatingsIntel. Jefferies initiated the shares of TKPPY in report on Monday, October 5 with “Buy” rating. The stock of TECHNIP ADS (OTCMKTS:TKPPY) has “Mkt Perform” rating given on Wednesday, January 6 by Bernstein. The stock has “Neutral” rating by Goldman Sachs on Wednesday, July 22. As per Monday, October 12, the company rating was downgraded by Citigroup. The company was upgraded on Wednesday, November 4 by Macquarie Research. The stock of TECHNIP ADS (OTCMKTS:TKPPY) earned “Reduce” rating by Nomura on Tuesday, September 8. The firm has “Outperform” rating by Credit Suisse given on Monday, September 19. See TECHNIP ADS (OTCMKTS:TKPPY) latest ratings:

The stock of Precipio, Inc. (NASDAQ:PRPO) hit a new 52-week low and has $0.68 target or 3.00% below today’s $0.70 share price. The 9 months bearish chart indicates high risk for the $8.41M company. The 1-year low was reported on Feb, 24 by Barchart.com. If the $0.68 price target is reached, the company will be worth $252,420 less. The stock decreased 3.97% or $0.029 during the last trading session, reaching $0.702. About 242,396 shares traded or 176.96% up from the average. Precipio, Inc. (NASDAQ:PRPO) has 0.00% since February 24, 2017 and is . It has underperformed by 16.70% the S&P500.

Precipio, Inc. provides diagnostic information to physicians and their patients worldwide. The company has market cap of $8.41 million. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. It currently has negative earnings.

It closed at $17.85 lastly. It is down 0.00% since February 24, 2017 and is . It has underperformed by 16.70% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>